CBLL
Ceribell, Inc.
Key Financials
Operating Income
$-58402000
↓ 47.1%
Net Income
$-53412000
↓ 32.0%
Revenue
$89.1M
↑ 36.1%
EPS (Diluted)
$-1.46
↑ 56.9%
Gross Profit
$78.3M
↑ 37.9%
Total Assets
$195.8M
↓ 13.1%
Total Liabilities
$40.5M
↑ 18.2%
Cash & Equivalents
$40.5M
↓ 79.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 10/2/2026 | View on SEC |
| 144 | 10/1/2026 | View on SEC |
| 4 | 9/17/2026 | View on SEC |
| 4 | 9/17/2026 | View on SEC |
| 144 | 9/15/2026 | View on SEC |
| 144 | 9/15/2026 | View on SEC |
| 4 | 9/10/2026 | View on SEC |
| 4 | 9/10/2026 | View on SEC |
| 144 | 9/8/2026 | View on SEC |
| 144 | 9/8/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CBLL |
| Company Name | Ceribell, Inc. |
| CIK | 1861107 |
| Sector | Electromedical & Electrotherapeutic Apparatus |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 3845 |
| SIC Description | Electromedical & Electrotherapeutic Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (800) 436-0826 |